An Insight on the Pathogenesis and Treatment of Systemic Lupus Erythematosus

Endocr Metab Immune Disord Drug Targets. 2018 Feb 13;18(2):110-123. doi: 10.2174/1871530318666171207145003.

Abstract

Background and objective: Systemic lupus erythematosus (SLE) is a diverse autoimmune disorder, evoked in response to self-immune system that leads to immune complex depositions and organ damage. The exact mechanism of SLE pathogenesis is still unclear but certain genetic and environmental factors have been suggested that could influence its pathogenesis.

Discussion: The modulation in B- and T- cell responses and genetic variations could lead to abnormal lymphocyte functions and the production of antibodies against the indigenous proteins and the immune complex depositions.

Conclusion: The present review highlights the various causatives of SLE, particularly the genetic alteration in B- and T-cell-related proteins. We have also delineated some of the available therapeutic strategies for the treatment of SLE.

Keywords: Cytokines; inflammation; interferons; pathogenesis; polymorphism; systemic lupus erythematosus..

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use
  • Apoptosis / drug effects
  • Autoimmunity* / drug effects
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology
  • Combined Modality Therapy / adverse effects
  • Combined Modality Therapy / trends
  • DNA Repair / drug effects
  • Drug Therapy, Combination / adverse effects
  • Drug Therapy, Combination / trends
  • Estrogens / adverse effects
  • Estrogens / therapeutic use
  • Genetic Predisposition to Disease
  • Humans
  • Lupus Erythematosus, Systemic / etiology*
  • Lupus Erythematosus, Systemic / genetics
  • Lupus Erythematosus, Systemic / immunology
  • Lupus Erythematosus, Systemic / therapy
  • Mutation
  • Phagocytosis / drug effects
  • Polymorphism, Genetic
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Estrogens